Sun Pharmaceutical Industries Inc.
Sun Pharmaceutical Industries Inc., commonly referred to as Sun Pharma, is a leading global pharmaceutical company headquartered in the United States. Founded in 1993, Sun Pharma has established a strong presence in various operational regions, including North America, Europe, and Asia, focusing on the development and manufacturing of a diverse range of pharmaceutical products.
Specialising in generic and specialty medications, Sun Pharma is renowned for its innovative formulations and high-quality standards. The company’s core offerings include treatments in areas such as psychiatry, neurology, cardiology, and dermatology, setting it apart with a commitment to research and development.
With a robust market position, Sun Pharma has achieved significant milestones, including numerous product approvals and a growing portfolio of over 200 generic products. Its dedication to improving patient outcomes and expanding access to essential medications underscores its reputation as a trusted leader in the pharmaceutical industry.
+25 vs industry average
Sun Pharmaceutical Industries Inc.’s score of 63 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Sun Pharmaceutical Industries Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Sun Pharmaceutical Industries Inc. yet.
Sun Pharmaceutical Industries Inc.'s reported carbon emissions
Sun Pharmaceutical Industries Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Sun Pharmaceutical Industries Limited, which may influence its climate commitments and emissions reporting.
As of now, there are no documented reduction targets or climate pledges from Sun Pharmaceutical Industries Inc. However, emissions data and performance metrics may be inherited from its parent company, Sun Pharmaceutical Industries Limited, which operates under the guidance of various sustainability initiatives, including the Carbon Disclosure Project (CDP). The emissions data cascaded from Sun Pharmaceutical Industries Limited may provide insights into the broader corporate climate strategy, although specific figures are not disclosed.
In the absence of direct emissions data and reduction targets, it is essential to monitor the company's future commitments and initiatives to understand its role in addressing climate change and reducing carbon emissions.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Sun Pharmaceutical Industries Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Sun Pharmaceutical Industries Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
Inherited from Sun Pharmaceutical Industries LimitedThe Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project